Temsirolimus and Dexamethasone in Treating Patients With Recurrent or Refractory Multiple Myeloma

Clinical trial NCT00693433 · COMPLETED

Trial details

NCT number: NCT00693433
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Refractory Multiple Myeloma Stage I Multiple Myeloma Stage II Multiple Myeloma Stage III Multiple Myeloma

Start date: 2008-12-01
Primary completion: 2010-08-01
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.